Tech Center 1600 • Art Units: 1615 1654
This examiner grants 64% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18613904 | COMPOSITIONS COMPRISING BIOACTIVE GLASS AND AMINO ACID | Non-Final OA | CORNING INCORPORATED |
| 18432605 | ANTIMICROBIAL BOTTLE WITH ANTIMICROBIAL SEAL | Final Rejection | Microban Products Company |
| 18546602 | AMORPHOUS FORM AND COMPOSITION CONTAINING SAID AMORPHOUS FORM | Final Rejection | OTSUKA PHARMACEUTICAL CO., LTD. |
| 18011335 | SAPONIN CONTAINING EXTRACTS PREPARED FROM HESPERALOE USEFUL IN THE TREATMENT OF NON-HUMAN ANIMALS | Final Rejection | KIMBERLY-CLARK WORLDWIDE, INC. |
| 18690379 | AQUEOUS COMPOSITION COMPRISING A FATTY DIALKYL ETHER, AN ANIONIC SURFACTANT WITH AT LEAST ONE CATIONIC COUNTERION AND A NONIONIC SURFACTANT | Non-Final OA | L'OREAL |
| 18591930 | COSMETIC COMPOSITION FOR ACNE CARE | Final Rejection | L'OREAL |
| 18640463 | METHOD OF PREPARING POUCH FILLING MATERIAL USING BINDER | Non-Final OA | KT&G Corporation |
| 18093654 | ORAL GEL COMPOSITIONS | Non-Final OA | Colgate-Palmolive Company |
| 18291029 | LIGHT-COLORED CATECHOL LIGNOSULFONATE SUNSCREEN MICROCAPSULE, AND PREPARATION THEREFOR AND USE THEREOF | Non-Final OA | South China University of Technology |
| 18023119 | COMPOSITION FOR AMELIORATING UNPLEASANT STATE CAUSED BY MENSTRUATION | Non-Final OA | ROHTO PHARMACEUTICAL CO., LTD. |
| 18016189 | COMPOSITIONS AND METHODS OF TREATING UPS-ASSOCIATED DISEASES | Final Rejection | Board of Supervisors of Louisiana State University and Agricultural and Mechanical College |
| 18700578 | LOW BACK PAIN TREATMENT | Non-Final OA | Persica Pharmaceuticals Ltd. |
| 18697581 | A Nano Emulsified Phyto-Drug For Transdermal Treatment of Diabetes | Non-Final OA | University of South Africa |
| 18585371 | SUNSCREEN PREPARATION | Non-Final OA | BEIERSDORF AG |
| 18568202 | DISSOLUTION RESISTANT TISSUE ADHERENT DRESSING APPLICATION AND ITS DELIVERY | Non-Final OA | TRICOL BIOMEDICAL, INC. |
| 18541626 | COMPOSITION COMPRISING AT LEAST ONE NATURAL OR SYNTHETIC N-ALKYLAMIDE AS ACTIVE SUBSTANCE AND ITS MANUFACTURING PROCESS | Non-Final OA | TILMAN |
| 18568415 | PHARMACEUTICAL COMPOSITION, PREPARATION, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Non-Final OA | WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD. |
| 18567140 | METHODS FOR THE PULSED DELIVERY OF BIOACTIVE AGENTS | Final Rejection | David Allen PULEO |
| 18525295 | COMPOSITIONS COMPRISING POROUS MICROPARTICLES AND METHODS OF USING THE SAME | Non-Final OA | WEST CHESTER UNIVERSITY |
| 18564552 | CO-AMORPHOUS FORMS FOR USE IN CANCER THERAPY | Non-Final OA | Zerion Pharma APS |
| 18562212 | ORODISPERSIBLE EFFERVESCENT TABLET COMPRISING BUDESONIDE FOR USE IN THE TREATMENT OF EOSINOPHILIC ESOPHAGITIS | Non-Final OA | Dr. Falk Pharma GmbH |
| 18552711 | ADHESIVE MICROCAPSULES FOR MECHANICALLY-RESPONSIVE THERAPEUTIC DELIVERY | Non-Final OA | THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARMENT OF VETERANS AFFAIRS |
| 18283585 | PHARMACEUTICAL COMPOSITION FOR IMPROVING CARDIAC FUNCTION | Final Rejection | CUORIPS INC. |
| 18551592 | SUPERABSORBENT HYDROGELS | Final Rejection | JUNION LABS PTE. LTD. |
| 18467324 | Compositions of Iboga Alkaloids and Methods of Treatment | Non-Final OA | Soneira Inc., P.B.C. |
| 18451355 | Food Contact Disinfecting/Sanitizing Formulation And Wipe | Final Rejection | ARXADA, LLC |
| 18276396 | INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF | Non-Final OA | Aerovate Therapeutics, Inc. |
| 18272796 | AMLODIPINE DRY SUSPENSION AND PREPARATION METHOD THEREFOR | Non-Final OA | APICHOPE BIO PHARMACEUTICAL CO., LTD. |
| 18195713 | BRAIN HEALTH SUPPLEMENTS | Final Rejection | Melaleuca, Inc. |
| 18034878 | COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING CORONAVIRUSES | Non-Final OA | NOVATEK THERAPEUTICS, LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy